A Phase 2 double blinded, randomised, placebo controlled dose-finding study to evaluate the safety tolerability and efficacy of Volixibat potassium an apical sodium-dependant bile acid transport inhibitor (ASBTi) in adults with non-alcoholic steatohepatitis (NASH) (SHIRE Study)
1st February 2017 - ongoing
Status:
Specialism: Liver.
Team: Professor Guruprasad Aithal.
Publications
Title |
---|
Grants
Title | Amount |
---|